Search for: [Abstract = "e children received some kind of pharmacological treatment \(n=112, 98,2%\). The most common medications given by the non\-medical people both in Polish study and the Registry included oral antihistaminic drugs \(AH1\) \(81,6 % vs 78%\), oral glucocorticosteroids \(GCS\) \(21,1% vs 52%\), beta\-agonist medications \(SABA\) \(18,4 vs 28%\). Pharmacotherapy provided by medical personnel both as the first, and second line of intervention was based on the following medications listed according to the order of their use – AH1 \(89,3%\), GCS \(83%\), and intravenous fluids \(61,3%\). The comparable rate of GCS use \(82%\) and slightly lower rate of AH1 use \(76%\) were reported in the patients records in the Registry. Adrenaline, as the first line intervention, was used in 39 patients in our analysis \(34,8%\), which was slightly higher compared to the Registry \(28%\), but overall the recorded rate was still too low. In the summary, careful analysis demonstrated that in this study almost 2\/3 children \(65,2%\) with severe anaphylaxis did not receive adrenaline as the first line intervention. Immediately following anaphylactic event, only 1\/3 patients received prescriptions for adrenaline for self\-administration, and less than 10% was trained on management of anaphylaxis in case of recurrent event. Administration of adrenaline in merely 1\/3 children with severe systemic reaction demonstrated its limited use in a"]

Number of results: 1